Novo Nordisk, Eli Lilly escalate fight over 340B drug pricing
What’s happening: Drugmakers Novo Nordisk and Eli Lilly are taking new steps to limit how hospitals and clinics access discounted medications through the federal 340B program. The companies are implementing policies that require providers to submit additional claims data or use specific pharmacies to receive discounted drugs, intensifying an ongoing dispute between pharmaceutical manufacturers and hospital systems.
Why it matters: The 340B program is a major revenue source for many safety-net hospitals and health systems, helping offset the cost of uncompensated care and community programs. Restrictions by large manufacturers could reduce program savings and create new administrative burdens for hospitals, potentially prompting legal challenges and policy intervention from federal regulators.
HHS reviews role of preventive care task force after court challenges
What’s happening: Federal officials are reassessing how the U.S. Preventive Services Task Force (USPSTF) operates following legal challenges to its authority. The review could lead to changes in how preventive service recommendations are approved or implemented under the Affordable Care Act, which requires insurers to cover many recommended services without cost-sharing.
Why it matters: Any change to the structure or authority of the USPSTF could affect which screenings and preventive services insurers must cover for patients at no cost. Hospitals and health systems could see shifts in patient demand, reimbursement patterns, and preventive care delivery depending on how federal officials modify the policy framework.
CMS delays rollout of rural health transformation funding
What’s happening: The Centers for Medicare and Medicaid Services has delayed the distribution of funding tied to its rural health transformation initiatives. The programs are designed to support innovative care models and stabilize struggling rural hospitals, but implementation timelines have slipped as CMS finalizes program details.
Why it matters: Rural hospitals and health systems are counting on these funds to support care redesign, workforce initiatives, and financial sustainability. Delays could prolong financial stress for rural providers and slow progress on federal strategies aimed at preventing rural hospital closures.
Americans trust doctors more than federal health agencies, poll suggests
What’s happening: Survey data analyzed by the Cato Institute suggests Americans place significantly more trust in their personal physicians than in federal public health agencies. The analysis argues that public health policy should rely more heavily on clinician relationships and patient trust rather than centralized messaging.
Why it matters: Trust dynamics influence public compliance with health guidance, vaccination campaigns, and preventive care initiatives. For health systems, the data reinforces the growing importance of physician communication and local credibility in shaping public health outcomes and patient behavior.
Covered California considers expanding lower-cost bronze plans
What’s happening: Covered California is examining changes that could make lower-premium bronze marketplace plans more accessible to residents. Policymakers are debating how to balance affordability with adequate coverage as enrollees face rising premiums and out-of-pocket costs.
Why it matters: Changes to marketplace plan design could influence patient coverage levels, financial risk, and utilization patterns. Hospitals may see shifts in payer mix and patient cost-sharing if more residents enroll in lower-premium plans that carry higher deductibles.
Early-stage colon cancers rising in adults under 50, screening may help
What’s happening: New findings highlight an increase in early-stage colorectal cancer diagnoses among adults under age 50. Researchers suggest expanded screening and earlier detection are helping identify cancers sooner, even as incidence rates continue to rise among younger populations.
Why it matters: Health systems nationwide are responding to changing screening recommendations and growing awareness of early-onset colorectal cancer. Increased screening demand could create opportunities for health systems to expand preventive services, outreach campaigns, and gastrointestinal care capacity.